CANC vs. BGIG ETF Comparison

Comparison of Tema Oncology ETF (CANC) to ETF Series Solutions Bahl & Gaynor Income Growth ETF (BGIG)

CANC

Tema Oncology ETF

CANC Description

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$28.18

Average Daily Volume

4,451

Number of Holdings ^*

* may have additional holdings in another (foreign) market

BGIG

ETF Series Solutions Bahl & Gaynor Income Growth ETF

BGIG Description

The fund is an actively managed exchange-traded fund ("ETF") that invests primarily in dividend-paying U.S.-listed equity securities of large capitalization companies, predominately those with a market capitalization greater than $7 billion.

Grade (RS Rating)

Last Trade

$29.91

Average Daily Volume

6,334

Number of Holdings ^*

* may have additional holdings in another (foreign) market

Performance

Period	CANC	BGIG
30 Days	-5.66%	0.92%
60 Days	-0.39%	7.10%
90 Days	5.35%	7.33%
12 Months	24.13%	30.40%

1 Overlapping Holdings

	Symbol	Grade	Weight in CANC	Weight in BGIG	Overlap
	MRK	F	4.26%	4.25%	4.25%

CANC Overweight 6 Positions Relative to BGIG

Symbol	Grade	Weight
REGN	D	6.07%
ARGX	A	4.19%
AMGN	D	3.78%
BPMC	F	3.3%
ILMN	C	3.27%
RVMD	B	3.13%

CANC Underweight 9 Positions Relative to BGIG

Symbol	Grade	Weight
AVGO	C	-6.58%
LLY	D	-5.77%
ABBV	A	-4.53%
MDLZ	C	-3.57%
PEP	D	-3.54%
PG	C	-3.3%
NEE	A	-3.19%
WMB	A	-3.02%
MMC	D	-2.95%

CANC: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Major Diagnostics & Research